Dana-Farber Cancer Institute - Merrimack Valley is a clinical research site located in Methuen, Massachusetts, United States 01844.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Dana-Farber Cancer Institute - Merrimack Valley has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: High-risk Smoldering Multiple Myeloma, Multiple Myeloma, Breast Neoplasms.
Sponsors: Omar Nadeem, MD, Eli Lilly and Company, Massachusetts General Hospital.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Dana-Farber Cancer Institute - Merrimack Valley has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana-Farber Cancer Institute - Merrimack Valley has 4 clinical trials on record, with 3 currently active. Their work covers High-risk Smoldering Multiple Myeloma, Multiple Myeloma, Breast Neoplasms.
Yes — Dana-Farber Cancer Institute - Merrimack Valley holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.